Acquiring Company
Eli Lilly and Company
Acquired Company
DICE Therapeutics
IndianapolisManufacturingBiotechnologyHealth CareMedicalPharmaceuticalBiotechnologyHealth CareTherapeuticsDescription
Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of DICE Therapeutics, Inc. (NASDAQ: DICE). The acquisition expands Lilly's immunology portfolio to include DICE's novel oral therapeutic candidates, including oral IL-17 inhibitors currently in clinical development, to treat chronic diseases in immunology.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Scilex Holding Company Announces The Consummation Of The Previously Announced Purchase Of All Of The Scilex Common Shares, Preferred Shares And Warrants Owned By Sorrento Therapeutics, Inc. (September 21, 2023)
- Cybin To Acquire Small Pharma Inc. (August 28, 2023)
- Theken Companies Acquires Visionair Solutions (August 22, 2023)
- Lilly To Acquire Versanis To Improve Patient Outcomes In Cardiometabolic Diseases (July 14, 2023)
- Caldera Medical Acquires Atlantic Therapeutics To Expand Portfolio In Women’S Health (September 6, 2023)
- Lilly Completes Acquisition Of Sigilon Therapeutics (August 14, 2023)
Who to call at Eli Lilly and Company, and when
When Eli Lilly and Company changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Eli Lilly and Company raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eli Lilly and Company, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eli Lilly and Company. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eli Lilly and Company makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired DICE Therapeutics?
DICE Therapeutics was acquired by Eli Lilly and Company, based in Indianapolis. The deal was reported on August 9, 2023. Lilly is a medicine company turning science into healing to make life better for people around the world. Eli Lilly and Company is publicly traded (LLY) and operates in Manufacturing.
When did Eli Lilly and Company acquire DICE Therapeutics?
Eli Lilly and Company's acquisition of DICE Therapeutics was reported on August 9, 2023. Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of DICE Therapeutics, Inc. (NASDAQ: DICE). Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does DICE Therapeutics do?
DICE Therapeutics, Inc. is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.